Search

Your search keyword '"Chow HY"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Chow HY" Remove constraint Author: "Chow HY" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
50 results on '"Chow HY"'

Search Results

3. Cultural barriers and facilitators of the parents for human papillomavirus (HPV) vaccination uptake by their daughters: A systematic review.

4. Prior disulfide bond-mediated Ser/Thr ligation.

6. A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine.

7. Arginine Is a Novel Drug Target for Arginine Decarboxylase in Human Colorectal Cancer Cells.

8. Enhanced sensitivity of neutralizing antibody detection for different AAV serotypes using HeLa cells with overexpressed AAVR.

9. Gossypol acetate: A natural polyphenol derivative with antimicrobial activities against the essential cell division protein FtsZ.

10. Development and Utility of a PAK1-Selective Degrader.

11. Studies on daptomycin lactam-based analogues.

12. A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants.

13. Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City.

14. Optimization of miR-22 expression cassette for rAAV delivery on diabetes.

15. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).

16. An atomic perspective on improving daptomycin's activity.

17. Evaluation of a Combined Multilocus Sequence Typing and Whole-Genome Sequencing Two-Step Algorithm for Routine Typing of Clostridioides difficile .

18. Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion.

19. Development of DHQ-based chemical biology probe to profile cellular targets for HBV.

20. Recombinant Bacillus caldovelox Arginase Mutant (BCA-M) Induces Apoptosis, Autophagy, Cell Cycle Arrest and Growth Inhibition in Human Cervical Cancer Cells.

21. The Effect of Conduction Exercise and Self-Acupressure in Treatment of Parkinson's Disease: A Pilot Study.

22. Establishing the Structure-Activity Relationship of Daptomycin.

23. Improved total synthesis of the antibiotic A54145B.

24. Enhanced Activity against Multidrug-Resistant Bacteria through Coapplication of an Analogue of Tachyplesin I and an Inhibitor of the QseC/B Signaling Pathway.

25. Methylation of Daptomycin Leading to the Discovery of Kynomycin, a Cyclic Lipodepsipeptide Active against Resistant Pathogens.

26. OPA-Based Bifunctional Linker for Protein Labeling and Profiling.

27. PEGylated recombinant human arginase as a drug for breast cancer.

28. Ligation Technologies for the Synthesis of Cyclic Peptides.

29. Total Synthesis and Structural Establishment/Revision of Antibiotics A54145.

30. Evaluation of the Aries Bordetella Assay for Detection and Identification of Bordetella pertussis in Nasopharyngeal Swab Specimens.

31. Intrinsic Cleavage of RNA Polymerase II Adopts a Nucleobase-independent Mechanism Assisted by Transcript Phosphate.

32. Effectiveness of ultraviolet disinfection in reducing hospital-acquired Clostridium difficile and vancomycin-resistant Enterococcus on a bone marrow transplant unit.

33. Group I Paks are essential for epithelial- mesenchymal transition in an Apc-driven model of colorectal cancer.

34. Influences of disulfide connectivity on structure and antimicrobial activity of tachyplesin I.

35. P-B Desulfurization: An Enabling Method for Protein Chemical Synthesis and Site-Specific Deuteration.

36. Qualitative and quantitative assessment of Illumina's forensic STR and SNP kits on MiSeq FGx™.

37. Systematic assessment of the performance of illumina's MiSeq FGx™ forensic genomics system.

38. Enabling N-to-C Ser/Thr Ligation for Convergent Protein Synthesis via Combining Chemical Ligation Approaches.

39. Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization.

40. Group I Paks as therapeutic targets in NF2-deficient meningioma.

41. Proteomics analysis of co-purifying cellular proteins associated with rAAV vectors.

42. Identification of a new class of FtsZ inhibitors by structure-based design and in vitro screening.

43. Pak2 kinase restrains mast cell FcεRI receptor signaling through modulation of Rho protein guanine nucleotide exchange factor (GEF) activity.

44. p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model.

45. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.

46. p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.

47. Development of a low-cost polymerase chain reaction-based method for studying differentially expressed genes in developing rice leaves.

48. Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches.

49. Acute calcific tendinitis of the hip: case report with magnetic resonance imaging findings.

50. Cardiovascular effects of Gardenia florida L. (Gardeniae Fructus) extract.

Catalog

Books, media, physical & digital resources